Redfin Option Alert: Mar 21 $9 Calls at the Ask: 6000 vs 2671 OI; Earnings 2/27 After Close 

Redfin Option Alert: Mar 21 $9 Calls at the Ask: 6000 @ $1.02 vs 2671 OI; Earnings 2/27 After Close Ref=$9.025

Redfin (NASDAQ:RDFN) 株価情報

REDFIN CORP

Redfin

Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments real estate services, rentals, mortgage, title, and monetization. The company generates the majority of its revenue from Real estate services.

Why Warren Buffett Turns To Kipling’s 1895 Poem “If—” When Markets Crash

News

Markets

RDFN

ウォーレン・バフェットが率いるバークシャー・ハサウェイ（NYSE:BRK）が、ニューヨークを拠点とするコンパス・リアルエステイトに不動産業事業の売却を交渉中との報道があった。

ウォーレン・バフェットは不動産事業の売却予定、アナリストは「米国の住宅価格の賭けではない」とコメント

Redfin Corp

TXO Partners, L.P. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXO#NYSE">TXO</a>) ("TXO") today announced the pricing of its public offering of $175 million of our common units, made up of 11,666,667 common units representing limited partner interests in TXO (the "common units") at price to the public of $15.00 per common unit. TXO has granted the underwriters an option to purchase up to an additional 1,750,000 common units at the public offering price, less underwriting discounts and commissions. The offering is expected to close on May 15, 2025, subject to customary closing conditions.
TXO expects to receive net proceeds of approximately $165.3 million, after deducting underwriting discounts and commissions and excluding any exercise of the underwriters' option to purchase additional common units. TXO intends to use the net proceeds from this offering, if consummated, to fund a portion of the cash consideration for the previously announced asset acquisition from White Rock Energy, LLC, a portfolio company of Quantum Capital Group (the "Acquisition"). The offering is not conditioned on the consummation of the Acquisition. Pending the closing of the Acquisition, and in the event that the Acquisition is not completed, the proceeds from the offering will be used to repay the outstanding borrowings under TXO's revolving credit facility and for general partnership purposes.

Offerings

TXO Partners, L.P. Announces Pricing Of $175M Public Offering Of 11.667M Common Units At A Price Of $15/Unit

Guidance

SGBX

Safe & Green Holdings Provides Corporate Update; To Evaluate High-Value Partnerships And Acquisitions Across US Energy Productio, Sustainable Technologies And Modular Construction Solutions

Today, Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) subsidiary Lockheed Martin España S.A. signed a significant industrial cooperation agreement with the Spanish Ministry of Defense, providing the Spanish defense industry with increased engineering and production capability. This agreement leads to the opportunity for Spanish Industry to compete for the production of Patriot Advanced Capability-3 (PAC-3) Missile Segment Enhancement (MSE) components. This agreement marks a major milestone in the company's efforts to strengthen defense supply chains, harnessing the best of Spanish, U.S. and greater European industry.
The agreement, signed during the International Defence and Security Exhibition of Spain, (FEINDEF) outlines a framework for future collaboration on industrial development projects in Spain with leading Spanish defense technology firms Sener and Oesía-Tecnobit. Sener will design and develop PAC-3 MSE actuators based on Lockheed Martin specifications and Oesía Tecnobit will produce specialized PAC-3 MSE cables and harnesses. Lockheed Martin España has been working closely with these companies since 2023.

Lockheed Martin Expands Industrial Cooperation In Spain With New PAC-3 MSE Agreement

Citigroup analyst Geoff Meacham upgrades Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) from Neutral to Buy and raises the price target from $600 to $700.

Upgrades

Price Target

Analyst Ratings

REGN

Citigroup Upgrades Regeneron Pharmaceuticals to Buy, Raises Price Target to $700

Saudi Arabian Mining Company ("Maaden" or the "Company", 1211 on the Saudi Exchange), one of the world's fastest growing mining companies, has signed an agreement with MP Materials Corp ("MP Materials") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>), the American fully integrated rare earth producer, to explore opportunities to establish a fully integrated, end-to-end rare earth supply chain.
A Memorandum of Understanding (MoU) was signed on the sideline of the U.S.-Saudi Investment Forum 2025, taking place in Riyadh.
This agreement combines world-class exploration and processing expertise to advance and de-risk the development of potential Rare Earth Element (REE) deposits across Saudi Arabia as it continues to position itself as a world-leading player in the critical minerals sector. Maaden and MP Materials aim to explore opportunities to jointly develop a vertically integrated rare earth supply chain in Saudi Arabia, including mining, separation, refining, and magnet production, to drive industrial depth and create value for downstream sectors.
 &nbsp;
 &nbsp;

Saudi Arabian Mining Agrees With MP Materials To Explore Opportunities To Establish Fully Integrated, End-To-End Rare Earth Supply Chain

Billionaire hedge-fund boss Bill Ackman hailed Sen. Ted Cruz's proposal to give every newborn American a $1,000 investment account, posting on X: "I have been a fan of this idea for years. It is great to see it finally happening."
What Happened: Ackman's praise followed Cruz's CNBC <a href="https://www.cnbc.com/video/2025/05/13/sen-ted-cruz-on-invest-america-act-allows-kids-to-climb-the-economic-ladder-much-faster.html">clip</a> touting the Invest America Act, which the Texas Republican says will &#8220;create an investment account for every newborn American child that the federal government will seed with $1,000.&#8221; A House version surfaced Tuesday in the Ways and Means Committee's budget package, signaling the plan's first real legislative traction.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I have been a fan of this idea for years. It is great to see it finally happening. <a href="https://t.co/kdSZkrch8X">https://t.co/kdSZkrch8X</a> <a href="https://t.co/AtspxvcVE2">https://t.co/AtspxvcVE2</a>
&mdash; Bill Ackman (@BillAckman) <a href="https://twitter.com/BillAckman/status/1922391975002566835?ref_src=twsrc%5Etfw">May 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See also: <a href="https://www.benzinga.com/general/entertainment/25/05/45403511/bill-gates-predicted-in-1995-that-one-day-computers-might-think-on-their-own-but-called-it-a-scary-thought-and-admitted-no-one-knows-when-that-will-happen">Bill Gates Once Warned That Computers Might Eventually Think On Their Own—But Admitted It Was A &#8216;Scary Thought&#8217; That &#8216;No One Knows When That Will Happen&#8217;</a>
Under the bill, each account would track a low-cost S&amp;P 500 index fund. Relatives could add up to $5,000 a year, and the balance could be tapped at 18 for college, a first home or a business launch. Cruz's office estimates the nest egg could hit roughly $170,000 by adulthood, assuming a 7 percent annual return.
What To Know: Backers frame the idea as program that would broaden stock ownership and "cultivate a generation of capitalists," in Cruz's words.
Critics, as per a <a href="https://www.houstonchronicle.com/politics/texas/article/ted-cruz-tax-cut-plan-20324854.php">report</a> by the Houston Chronicle, counter that seeding every baby — about 3.6 million births a year — could cost billions and lacks income caps, raising deficit alarms. House Republicans rebranded the accounts "MAGA Savings" in their draft, reflecting former President Donald Trump's push to add pro-growth sweeteners to a broader 2017 tax-cut extension.
Even with Ackman's Wall Street clout behind it, the measure faces a steep climb in a divided Congress. But the financier's endorsement echoes a rare bipartisan appeal of giving every American a personal stake in the market from day one.
Read next: <a href="https://www.benzinga.com/25/05/45404338/wall-streets-most-accurate-analysts-spotlight-on-3-tech-and-telecom-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Tech And Telecom Stocks Delivering High-Dividend Yields</a>

Education

Personal Finance

General

Sen. Ted Cruz Wants To Give Americans $1,000 At Birth To Invest, Bill Ackman Says He's 'Been A Fan Of This Idea For Years'

ATAI Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAI#NASDAQ">ATAI</a>) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.18) by 16.67 percent. This is a 11.76 percent increase over losses of $(0.17) per share from the same period last year. The company reported $1.55 million in sales this quarter.

Earnings

Earnings Beats

ATAI

ATAI Life Sciences Q1 EPS $(0.15) Beats $(0.18) Estimate, Sales $1.55M

Citigroup analyst Geoff Meacham downgrades AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) from Buy to Neutral and lowers the price target from $210 to $205.

Downgrades

ABBV

Citigroup Downgrades AbbVie to Neutral, Lowers Price Target to $205

Earnings Outlook
The Company has raised its full-year 2025 guidance for new transaction funding outside of the Lennar Master Program to $1.5 billion, up from the previously announced $1 billion, driven by heightened demand.
Accordingly, the Company has also increased year-end quarterly earnings per share run-rate to a range of $0.69 to $0.71.

Raised Its FY25 Guidance For New Transaction Funding Outside Of The Lennar Master Program To $1.5B, Up From The Previously Announced $1B, Driven By Heightened Demand;  Increased Year-End Quarterly Earnings Per Share Run-Rate To A Range Of $0.69 To $0.71.

Feasibility endpoint achieved; rapid Ki‑67 suppression and substantial MRI‑confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4427161-1&amp;h=1470666501&amp;u=https%3A%2F%2Fatossatherapeutics.com%2F&amp;a=Atossa+Therapeutics%2C+Inc.">Atossa Therapeutics, Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOS#NASDAQ">ATOS</a>) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today reported full results from the Phase 2 Endocrine Optimization Pilot (EOP) sub‑study within the I‑SPY 2 TRIAL evaluating low‑dose oral (Z)‑endoxifen (10 mg daily) as a neoadjuvant treatment in 20 women with stage II/III estrogen‑receptor–positive (ER+), HER2‑negative breast cancer.

ATOS

Atossa Therapeutics Reports Full Results From Phase 2 EOP Sub‑Study Within I‑SPY 2 Trial Evaluating Low‑Dose Oral (Z)‑Endoxifen As Neoadjuvant Treatment In 20 Women With Stage II/III ER+, HER2‑Negative Breast Cancer

Millrose Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRP#NYSE">MRP</a>) reported quarterly earnings of $0.39 per share.

Millrose Properties Q1 EPS $0.39

Antalpha Platform Holding Company ("Antalpha" or the "Company") today announced the pricing of its initial public offering of 3,850,000 ordinary shares at a price to the public of $12.80 per ordinary share. The ordinary shares have been approved for listing and are expected to begin trading on the Nasdaq Global Market on May 14, 2025, under the ticker symbol "ANTA." The offering is expected to close on May 15, 2025, subject to customary closing conditions.
Antalpha has granted the underwriters a 30-day option to purchase an additional 577,500 ordinary shares to cover over-allotments in connection with the offering.

IPOs

ANTA

Antalpha Announces Pricing Of Initial Public Offering Of 3.85M Shares At A Price Of $12.80 Per Share

Citigroup analyst Arthur Truslove downgrades UL Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ULS#NYSE">ULS</a>) from Buy to Neutral and raises the price target from $60.5 to $71.

Citigroup Downgrades UL Solutions to Neutral, Raises Price Target to $71

IO Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.38) by 10.53 percent. This is a 13.33 percent decrease over losses of $(0.30) per share from the same period last year.

IOBT

IO Biotech Q1 EPS $(0.34) Beats $(0.38) Estimate

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the communication services sector.
<h3 class="wp-block-heading">Shutterstock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSTK#NYSE">SSTK</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.83%</li>
<li>JMP Securities analyst Andrew Boone reiterated a Market Perform rating on May 5, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Needham analyst Bernie McTernan maintained a Buy rating and cut the price target from $45 to $30 on March 7, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On May 2, the company posted downbeat quarterly results</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514">SSTK news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514"><img loading="lazy" decoding="async" width="896" height="811" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044751/image-156.png" alt="" class="wp-image-914631" style="width:590px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044751/image-156.png 896w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044751/image-156-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044751/image-156-768x695.png 768w" sizes="(max-width: 896px) 100vw, 896px" /></a></figure>
<h3 class="wp-block-heading">Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.35%</li>
<li>Tigress Financial analyst Ivan Feinseth maintained a Buy rating and raised the price target from $55 to $56 on April 28, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Scotiabank analyst Maher Yaghi maintained a Sector Perform rating and increased the price target from $48.5 to $49 on April 23, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On May 13, Verizon announced a $5 billion commitment to continue investing in America and supporting small businesses.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514">latest VZ news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514"><img loading="lazy" decoding="async" width="907" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044824/image-157.png" alt="" class="wp-image-914632" style="width:698px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044824/image-157.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044824/image-157-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044824/image-157-768x709.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">Nexstar Media Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXST#NASDAQ">NXST</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 4.27%</li>
<li>Benchmark analyst Daniel Kurnos maintained a Buy rating and raised the price target from $215 to $220 on May 9, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Wells Fargo analyst Steven Cahall maintained an Overweight rating and cut the price target from $216 to $200 on May 1, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On May 8, Nexstar Media Group reported better-than-expected first-quarter EPS results.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest NXST <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514"><img loading="lazy" decoding="async" width="895" height="826" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044903/image-158.png" alt="" class="wp-image-914635" style="width:671px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044903/image-158.png 895w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044903/image-158-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044903/image-158-768x709.png 768w" sizes="(max-width: 895px) 100vw, 895px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

Dividends

Pre-Market Outlook

Trading Ideas

NXST

SSTK

Wall Street's Most Accurate Analysts Spotlight On 3 Tech And Telecom Stocks Delivering High-Dividend Yields

Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) affirms FY2025 sales outlook from $30.00 million to $30.00 million vs $40.20 million estimate.

ALUR

Allurion Technologies Affirms FY2025 Sales Guidance of $30.00M vs $40.20M Est

WIIM

IXHL

Incannex Healthcare shares are trading higher after the company completed patient dosing in the Phase 2 portion of its Phase 2/3 RePOSA study of IHL-42X for obstructive sleep apnea.

Aprea Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APRE#NASDAQ">APRE</a>) reported quarterly losses of $(0.66) per share. This is a 1.49 percent increase over losses of $(0.67) per share from the same period last year. The company reported $162.46 thousand in sales this quarter. This is a 57.31 percent decrease over sales of $380.57 thousand the same period last year.

APRE

Aprea Therapeutics Q1 EPS $(0.66) Up From $(0.67) YoY, Sales $162.46K Down From $380.57K YoY

Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.35) by 31.43 percent. This is a 85.37 percent increase over losses of $(1.64) per share from the same period last year.

BNTC

Benitec Biopharma Q3 EPS $(0.24) Beats $(0.35) Estimate

Kalaris Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLRS#NASDAQ">KLRS</a>) reported quarterly losses of $(2.52) per share which missed the analyst consensus estimate of $(1.17) by 115.38 percent. This is a 3.08 percent increase over losses of $(2.60) per share from the same period last year.

Earnings Misses

KLRS

Kalaris Therapeutics Q1 EPS $(2.52) Misses $(1.17) Estimate

Press Releases

Redfin Reports First Quarter 2025 Financial Results

Redfin Reports Sending 2 Kids to Daycare Costs More Than Rent in Most Major U.S. Metros

Washington, D.C. Housing Inventory Jumps Record 25% Amid Federal Layoffs

Redfin Reports Record-High Costs, Economic Unease Are Stunting This Spring's Homebuying Season

Redfin Reports Demand For Vacation Homes Drops to Lowest Level Since at Least 2018

The Homes Americans Are Buying Are Older Than Ever

Redfin Reports U.S. Asking Rents Fell 1% Year Over Year in April—Biggest Drop in 14 Months

Redfin Report: 10 Places Where You Can Buy a Home For Under $300,000

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVDX, RDFN, AZEK, TURN on Behalf of Shareholders

Redfin and Magnite Join Forces to Give Advertisers Priority Access to Audience Targeting Across the Homebuying Journey

AVDX

AZEK

MGNI

TURN

Altisource Portfolio Solutions S.A. - Common Stock

Altisource Portfolio

KE Holdings Inc American Depositary Shares (each representing three Class A Ordinary Shares)

Comments

Redfin

Unusual Options Activity for

ニュース

パートナーシップ

ベンジンガ・グローバル